GGrantIndex
Sort

261,768 grants matching gene therapy

Rhesus Macaque Model of Accelerated Aging

$844,589
Elizabeth Schmidt Didier · Tulane University Of Louisiana · R56 · FY2016 · AG

eCD4-Ig for preventing and treating obstetric HIV infection

$844,588
Mauricio De Aguiar Martins · Scripps Florida · R01 · FY2020 · HD

Transcriptional Control of Neuroinflammation in Alzheimer's Disease

$844,584
Ming-Ming Zhou · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · AG

Targeting PD-1 Pathway for Functional Cure of AIDS

$844,556
Rama Rao Amara · Emory University · R37 · FY2017 · AI

Development of an mRNA-Based Therapeutic HIV/AIDS Vaccine

$844,491
Afamefuna Okoye · Oregon Health & Science University · R01 · FY2021 · AI

Transcriptional Control of Neuroinflammation in Alzheimer's Disease

$844,476
Ming-Ming Zhou · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · AG

The integrated stress response in cognitive disorders

$844,472
Paul Pfaffinger · Baylor College Of Medicine · R01 · FY2025 · NS

INTEGRATIVE GENOMICS OF CHILDHOOD INTERSTITIAL LUNG DISEASE

$844,386
Benjamin Alexander Raby · Boston Children'S Hospital · R01 · FY2024 · HL

Determinants of HIV latency in CD4+ T lymphocytes

$844,304
Viviana A Simon · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · AI

Fibroblast orchestration of the immune response in pancreatic cancer

$844,294
Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · U01 · FY2022 · CA

Cholesterol reduction and cardiovascular risk in Type 1 diabetes

$844,283
Ira Jay Goldberg · New York University School Of Medicine · R01 · FY2025 · HL

BMP Inhibitors to Treat Fibrodysplasia Ossificans Progressiva

$844,260
Philip Sanderson · National Center For Advancing Translational Sciences · ZIA · FY2018 · TR

HIV-1 subtype, specific drug resistance in patients failing Dolutegravir-based 1st, 2nd or 3rd line regimens: the International epidemiological Databases to Evaluate AIDS (IeDEA)

$844,255
Matthias Egger · Universitat Bern · R01 · FY2024 · AI

Cholesterol reduction and cardiovascular risk in Type 1 diabetes

$844,212
Ira Jay Goldberg · New York University School Of Medicine · R01 · FY2024 · HL

The Functional Consequences of the 17q12 Asthma Susceptibility Locus

$844,198
Benjamin Alexander Raby · Brigham And Women'S Hospital · R01 · FY2017 · HL

CHEETAH Center for the Structural Biology of HIV Infection, Restriction, and Viral Dynamics

$844,173
Owen W. Pornillos · University Of Utah · U54 · FY2024 · AI

Cholesterol reduction and cardiovascular risk in Type 1 diabetes

$844,142
Ira Jay Goldberg · New York University School Of Medicine · R01 · FY2023 · HL

Development of Nociceptin Receptor Agonists for Post-Traumatic Stress Disorder

$844,016
Shaun P Brothers · University Of Miami School Of Medicine · R01 · FY2016 · MH

Impact of Zika Virus Infection on Fetal Innate and Adaptive Immunity

$844,016
Kristina M Adams Waldorf · University Of Washington · R01 · FY2025 · AI

Multiomic strategies to assess HIV reservoir persistence

$844,008
Michael R Betts · University Of Pennsylvania · R01 · FY2025 · AI

Multiomic strategies to assess HIV reservoir persistence

$844,008
Michael R Betts · University Of Pennsylvania · R01 · FY2024 · AI

Autoimmune features of neurodegenerative disorders

$844,007
David Sulzer · Columbia University Health Sciences · R01 · FY2019 · NS

Molecular epidemiology of acute lymphoblastic leukemia in children with Down syndrome

$843,979
Karen R Rabin · Baylor College Of Medicine · R01 · FY2023 · CA

Near-IR Photorelease Chemistry: Discovery and Applications

$843,978
Martin Schnermann · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Host Glycomic Modulation of HIV-associated Neuro-inflammation During Viral Suppression

$843,928
Mohamed Abdel Mohsen · Wistar Institute · R01 · FY2021 · NS